Skip to Main Content

Can pharma get along post-pandemic? How will we know when the Covid-19 crisis is over? And is it OK to feel optimistic?

We discuss all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. First, we discuss Merck’s decision to help Johnson & Johnson manufacture vaccine doses and whether it’ll be a turning point for the drug industry or a relic of Covid-19 history. Then, as we near the one-year anniversary of the pandemic, STAT’s Andrew Joseph joins us to explain what experts think is in store in the months and years to come. Finally, Ashish Jha, dean of Brown University’s School of Public Health, joins us to explain why he’s optimistic about summer 2021.

For more on what we cover, here’s the news on Merck and J&J; here’s the story on the next stage of the pandemic; here’s where you can subscribe to the First Opinion Podcast; and here’s our complete coverage of the coronavirus pandemic.


Be sure to sign up on Apple PodcastsStitcherGoogle Play, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].


Interested in sponsoring a future episode of “The Readout LOUD”? Email us at [email protected].